These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29055359)

  • 1. Update in Current Diagnostics and Therapeutics of Dry Eye Disease.
    Thulasi P; Djalilian AR
    Ophthalmology; 2017 Nov; 124(11S):S27-S33. PubMed ID: 29055359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
    Versura P; Profazio V; Campos EC
    Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications.
    Sullivan BD; Crews LA; Messmer EM; Foulks GN; Nichols KK; Baenninger P; Geerling G; Figueiredo F; Lemp MA
    Acta Ophthalmol; 2014 Mar; 92(2):161-6. PubMed ID: 23279964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease.
    La Porta Weber S; Becco de Souza R; Gomes JÁP; Hofling-Lima AL
    Am J Ophthalmol; 2016 Mar; 163():167-173.e1. PubMed ID: 26701271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
    Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
    Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes.
    Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP
    Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Care for Patients with Dry Eye Symptoms: See What the Experts Say.
    Lin MC; Polse KA
    Optom Vis Sci; 2015 Sep; 92(9):e342-9. PubMed ID: 26176354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease.
    Downie LE
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7260-8. PubMed ID: 26544794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
    Sullivan BD; Crews LA; Sönmez B; de la Paz MF; Comert E; Charoenrook V; de Araujo AL; Pepose JS; Berg MS; Kosheleff VP; Lemp MA
    Cornea; 2012 Sep; 31(9):1000-8. PubMed ID: 22475641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear osmolarity in the diagnosis and management of dry eye disease.
    Lemp MA; Bron AJ; Baudouin C; Benítez Del Castillo JM; Geffen D; Tauber J; Foulks GN; Pepose JS; Sullivan BD
    Am J Ophthalmol; 2011 May; 151(5):792-798.e1. PubMed ID: 21310379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
    Zhao CS; Chen Y; Ying GS; Asbell PA;
    Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dry eye.
    McGinnigle S; Naroo SA; Eperjesi F
    Surv Ophthalmol; 2012; 57(4):293-316. PubMed ID: 22726587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.
    Gumus K; Pflugfelder SC
    Am J Ophthalmol; 2021 Jul; 227():35-44. PubMed ID: 33571473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
    Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
    Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location and pattern of non-invasive keratographic tear film break-up according to dry eye disease subtypes.
    Kim J; Kim JY; Seo KY; Kim TI; Chin HS; Jung JW
    Acta Ophthalmol; 2019 Dec; 97(8):e1089-e1097. PubMed ID: 31062499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.